Equitec Proprietary Markets’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Equitec Proprietary Markets’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20,100	Closed	-$772K	–	150
2023 Q2	$772K	Buy	+20,100	New	+$516K	0.23%	49

Equitec Proprietary Markets's KDNY Position: Q3 2023 in Review

Equitec Proprietary Markets sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 20,100 shares — an estimated $772K sold.

Equitec Proprietary Markets first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $772K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Equitec Proprietary Markets reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Equitec Proprietary Markets sold 20,100 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $772K.
Equitec Proprietary Markets first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Equitec Proprietary Markets's Chinook Therapeutics, Inc. Common Stock position peaked at $772K in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Equitec Proprietary Markets's 13F filing for Q3 2023, filed 17 Oct 2023.